Literature DB >> 22425286

Effects of chronic kidney disease on blood cells membrane properties.

Z Kaderjakova1, I Lajdova, M Horvathova, M Morvova, L Sikurova.   

Abstract

Chronic kidney disease (CKD) is progressive loss of renal function associated among others with increased intracellular calcium concentration. The purpose of this study was to identify the effects of CKD on cell membrane properties such as human red blood cell Ca(2+) ATPase activity, lymphocyte plasma membrane P2X(7) receptor expression and function. This could help us in elucidating the origin of increased calcium concentration in blood cells. We found out Ca(2+) ATPase activity is decreased in early stage CKD patients resulting in altered calcium removal from cytoplasm. By means of flow cytometry we assessed that P2X(7) receptor expression on lymphocyte membrane is 1.5 fold increased for CKD patients. Moreover, we detected an increased uptake of ethidium bromide through this receptor in CKD at basal conditions. It means CKD lymphocyte membranes contain more receptors which are more permeable thus allowing increased calcium influx from extracellular milieu. Finally, we can state alterations in blood cell membranes are closely linked to CKD and may be responsible for intracellular calcium accumulation.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425286     DOI: 10.1016/j.bioelechem.2012.02.006

Source DB:  PubMed          Journal:  Bioelectrochemistry        ISSN: 1567-5394            Impact factor:   5.373


  2 in total

1.  The Impact of Vitamin D3 Supplementation on Mechanisms of Cell Calcium Signaling in Chronic Kidney Disease.

Authors:  Ingrid Lajdova; Viera Spustova; Adrian Oksa; Zuzana Kaderjakova; Dusan Chorvat; Marcela Morvova; Libusa Sikurova; Alzbeta Marcek Chorvatova
Journal:  Biomed Res Int       Date:  2015-05-04       Impact factor: 3.411

2.  Epoetin beta pegol for treatment of anemia ameliorates deterioration of erythrocyte quality associated with chronic kidney disease.

Authors:  Ken Aizawa; Ryohei Kawasaki; Yoshihito Tashiro; Yasushi Shimonaka; Michinori Hirata
Journal:  BMC Nephrol       Date:  2018-01-27       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.